The 81st Annual Meeting of the Japanese Society of Hematology

Presentation information

Oral Session

Oral Session 1-12D ALL: Clinical Trials

Fri. Oct 11, 2019 4:30 PM - 5:30 PM No.12 (Tokyo International Forum, 5F G510)

Chair: Yoshihiro Hatta (Hematology and Rheumatology, Nihon University School of Medicine)

[OS1-12D-3] Frontline inotuzumab with low-intensity vs. intensive therapy for older patients with Ph-neg ALL

Koji Sasaki1, Hagop Kantarjian1, Nicholas Short1, Farhad Ravandi1, Maria Khouri1, Guillermo Garciamanero1, Naval Daver1, Tapan Kadia1, Marina Konopleva1, Nitin Jain1, Ghayas Issa1, Jovitta Jacob1, Rebecca Garris1, Musa Yimaz1, Philip Tompson1, Patrice Nasnas1, Naveen Pemmaraju1, Jorge Cortes1, Susan Obrien2, Elias Jabbour1 (1.MD Anderson Cancer Center, Houston, TX, U.S.A., 2.The University of California, Irvine)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.

Password